Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer (Q43873674)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 7 February 2013

Language	Label	Description	Also known as
English	Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer	scientific article published on 7 February 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Rui-chao Zeng

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Wei Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Xing-qiang Yan

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Zhi-qiang Ye

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

En-dong Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Du-ping Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Xiao-hua Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Guan-li Huang

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

7 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

477

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mammography facility characteristics associated with interpretive accuracy of screening mammography

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Real-time expression profiling of microRNA precursors in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

MicroRNA gene expression deregulation in human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

A microRNA-based gene dysregulation pathway in Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Circulating microRNAs in breast cancer and healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Subtypes of breast cancer show preferential site of relapse

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0477-Z

21 January 2018

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 oncogene expression in estrogen receptor-positive and negative breast carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased serum miR-181a is a potential new tool for breast cancer screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of tumor markers in southern Indian breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23389917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-013-0477-Z

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43873674&oldid=2206308139"